CompletedPhase 2NCT01498419
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Global Alliance for TB Drug Development
- Principal Investigator
- Rodney Dawson, MDUniversity of Cape Town
- Intervention
- Moxifloxacin (M)(drug)
- Enrollment
- 207 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2012 – 2013
Study locations (8)
- Task Applied Science, Karl Bremer Hospital, Cape Town, South Africa
- University of Cape Town Lung Institute (Pty) Ltd, Cape Town, South Africa
- KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Durban, South Africa
- CHRU Themba Lethu Clinic, Johannesburg, South Africa
- Klerksdorp Tshepong Hospital, Klerksdorp, South Africa
- The Aurum Institute: Tembisa Hospital, Tembisa, South Africa
- Ifakara Health Institute, Bagamoyo, Tanzania
- Mbeya Medical Research Programme, Mbeya, Tanzania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01498419 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07517445Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGPHASE2NCT07525427Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University